UPDATE : Wednesday, June 26, 2019
상단여백
Why people still ask if AIDS is preventable
The government has granted insurance benefit to Gilead’s Truvada (tenofovir...
by Kim Yun-mi  |  2019-06-26 17:02
라인
Expat students exempted from mandatory health insurance enrollment, for now
The Ministry of Health and Welfare has decided to exempt foreign students f...
by Lee Han-soo  |  2019-06-26 15:32
라인
Severance finds new gingival fibromatosis diagnostic biomarker
Researchers at Severance Hospital have found a new biomarker for diagnosing...
by Lee Han-soo  |  2019-06-26 15:31
라인
Voluntary nullifications of drug license tripled in H1
An increasing number of pharmaceutical companies voluntarily canceled the l...
by Lee Hye-seon  |  2019-06-26 14:25
라인
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan
Seoul Pharmaceuticals has signed an agreement with Loghman Pharmaceutical o...
by Lee Han-soo  |  2019-06-26 13:58
라인
Patients with ‘Invossa stigma’ struggle to get treatment, insurance
“I received Invossa injection in January, but the pain got worse. I’m getti...
by Jeong Sae-im  |  2019-06-26 13:22
라인
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia
Novartis has reaffirmed the long-term success of Tasigna (Ingredient: Nilot...
by Lee Han-soo  |  2019-06-26 11:39
라인
Huons Global launches new BTX in Korea
Huons Global plans to launch a new botulinum toxin (BTX) product in Korea. ...
by Lee Han-soo  |  2019-06-26 10:52
라인
Hanmi, Sanofi revise accord on co-developing diabetes drug
Hanmi Pharmaceutical said it has signed a revised agreement with Sanofi to ...
by Lee Han-soo  |  2019-06-25 17:36
라인
‘Imbruvica raised survival rate of mantle cell lymphoma patients’
“Imbruvica works better than any other existing chemotherapy in relapsed an...
by Kim Yun-mi  |  2019-06-25 15:34
라인
CHA Biotech to transfer SCRMI’s shares, technology to AIRM
CHA Biotech said that it would transfer shares and technologies of Stem Cel...
by Lee Han-soo  |  2019-06-25 15:25
라인
Oscotech wins exception policy for continued R&D for new drugs
The stock market regulator granted Oscotech to become the third KOSDAQ-list...
by Jeong Sae-im  |  2019-06-25 14:11
라인
Regulator OKs P3 trial for Eisai's Alzheimer treatment
The Ministry of Food and Drug Safety has approved the phase 3 clinical tria...
by Lee Han-soo  |  2019-06-25 14:09
라인
Novartis’ Cosentyx shows durable, comprehensive treatment for psoriatic disease
Novartis has released new data on five-year long-term immunogenicity and in...
by Lee Han-soo  |  2019-06-25 14:09
라인
Celltrion denies delay in local license application for HIV drug Temixys
The Ministry of Food and Drug Safety and Celltrion said rumors about the dr...
by Lee Hye-seon  |  2019-06-25 10:56
라인
'Elderly patients with atrial fibrillation have higher risk of dementia'
Researchers at Severance Hospital have found that elderly patients aged 60 ...
by Lee Han-soo  |  2019-06-24 15:50
라인
Latecomer experimental drug no better than Dupixent in trial
Pharmaceutical firms have strived to make latecomer drugs to beat Dupixent ...
by Kim Yun-mi  |  2019-06-24 15:49
라인
Daewoong wins new indications for Nabota
Daewoong Pharmaceutical's Nabota, its botulinum toxin (BTX) strain, has...
by Lee Han-soo  |  2019-06-24 14:47
라인
‘Expensive immunotherapies are not cure-all’
“Immunotherapies are increasingly drawing attention, but they cannot solve ...
by Park Gi-taek  |  2019-06-24 14:46
라인
Kang Stem Biotech completes P3 trials for stem cell-based atopy treatment
Kang Stem Biotech has completed the subject evaluation of phase 3 clinical ...
by Lee Han-soo  |  2019-06-24 12:19
여백
여백
여백
Back to Top